What Sanofi’s withdrawal from diabetes tech tells us about digital health
In health care, major drug makers have sought to collaborate with health tech up-and-comers. It doesn't always work out.
A version of this story appeared in STAT’s Health Tech newsletter. Click here to subscribe.
In health care, major drug makers have sought to collaborate with health tech up-and-comers. And on the surface, there’s good reason to think
